22157.jpg
Imutex's FLU-v Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032: Focus on United States,Germany, France, Italy, Spain, United Kingdom, and Japan
January 31, 2024 04:06 ET | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "FLU-v Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
22157.jpg
Metronidazole Market Forecast to 2032: Highlights Trends and the Competitive Landscape in CDI Treatment
January 30, 2024 06:44 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Metronidazole Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This insightful report provides...
22157.jpg
Bacteria-Based Agricultural Microbials Market Experiences Strong Growth with Focus on Organic Solutions
January 29, 2024 19:01 ET | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Bacteria-based Agricultural Microbials Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Emerging trends and...
22157.jpg
Vancomycin Drug Insights and Market Forecast to 2032 for Clostridium Difficile Infection Treatment in Key Global Regions
January 29, 2024 12:38 ET | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Vancomycin Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report presents an in-depth...
22157.jpg
Levofloxacin Market Forecast Reveals Rapid Growth in Asia-Pacific Region and Advancements in Targeted Therapies
January 29, 2024 11:15 ET | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Levofloxacin Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global attention turns to the recent...
22157.jpg
Global Pseudomonas Aeruginosa Infection Treatment Market Research Report 2024
January 29, 2024 09:35 ET | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Pseudomonas Aeruginosa Infection Treatment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. As the healthcare...
22157.jpg
Global Hepatitis Therapeutics Market On The Rise: Projected Growth of USD 18.8 Billion By 2030 with North America Leading the Way
January 24, 2024 06:12 ET | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Hepatitis Therapeutics Market 2030 by Hepatitis Type, Drug Class, Drug Type, End-user and Distribution Channel and Region - Partner &...
22157.jpg
Global Hepatitis B Tests Market Forecasts to 2033: In-Depth Analysis of Segments, Regulatory Landscape, and Emerging Trends
January 23, 2024 11:23 ET | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033" report has been added to ResearchAndMarkets.com's...
Global Pseudomonas Aeruginosa Infection Treatment Market
Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024: A USD 4.07 Billion Market by 2034, with Novel Antibiotics and Combination Therapies Emerging
January 22, 2024 05:18 ET | Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Pseudomonas Aeruginosa Infection Treatment Market" report has been added to ResearchAndMarkets.com's offering. The global pseudomonas...
22157.jpg
Global COVID-19 Nucleic Acid Amplification Tests (NAATs) Clinical Pipeline Research Report 2023: Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape
January 16, 2024 13:08 ET | Research and Markets
Dublin, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and...